Well Told Grants

Federal grant programs / Executive Office of the President

Research and Data Analysis (95.007)

Research and Data Analysis (Assistance Listing 95.007) is run by the Office of the National Drug Control Policy, part of the Executive Office of the President. It awarded $9.2 million in 10 grants from fiscal 2021 to 2025, about $915,665 per award on average. No funding opportunity is open on Grants.gov right now.

The typical award was $349,901. Half of the 10 awards fell between $181,250 and $1.1 million, and they ranged from $55,999 to $3.0 million.

Key findings

What the program funds

The purpose of research and data analysis is to inform policy formulation and assessment. The work involves research and analysis of data as it pertains to drug policy.

From the federal Assistance Listing. Read the full listing on SAM.gov.

Open opportunities

No opportunity under this program is open or forecast on Grants.gov right now. Programs often post once a year, so the funding history below shows what to expect.

Rules from the program listing

Who can apply

Applicants must have expert knowledge and extensive experience in conducting research and analysis to include higher educational institutions and hospitals. Applicants must also ensure compliance with all federal laws, regulations, Executive Orders, and public policies governing financial assistance awards.

What the money can and cannot pay for

ONDCP is seeking a provider to conduct research and data analysis on relevant drug topics.

Matching requirements

Statutory Formula: Title 2, Part 3603, Subpart 1,Public Law P.L. 109-469.Authority: 21 U.S.C. 1706; 21 U.S.C. 1703(d), 1703(f), 21 U.S.C. 1701, 21 U.S.C. 1521-1548, 21 U.S.C. 2001-2003, Office of National Drug Control Policy Reauthorization Act of 2006, P.L 109-469 (2006), 2 CFR part 200. Source: 79 FR 76105, Dec. 19, 2014, unless otherwise noted. § 3603.1 Adoption of 2 CFR Part 200. Under the authority listed above, the Executive Office of the President, Office of National Drug Control Policy (ONDCP) adopts the Office of Management and Budget (OMB) Guidance in 2 CFR part 200. Thus, this part gives regulatory effect to the OMB guidance and supplements the guidance as needed for ONDCP.Matching requirements are not applicable to this assistance listing. MOE requirements are not applicable to this assistance listing.

Award range and average, in the agency's words

$150,000 to $3,000,000

Quoted from the program's federal Assistance Listing. The notice of funding opportunity is the official source for each competition's rules.

Funding history and past recipients

From fiscal 2021 to 2025, Research and Data Analysis (95.007) awarded $9.2 million across 10 grant awards, an average of $915,665 per award.

Largest recipients, fiscal 2021 to 2025
RecipientStateAwardsAmount
University of BaltimoreMaryland2$5.9 million
National Association of County and City Health OfficialsDistrict of Columbia1$1.2 million
National Foundation for the Centers for Disease Control & Prevention, Inc.Georgia1$700,000
University of Maryland, College ParkMaryland3$574,998
American College of Medical Toxicology, Inc.Arizona1$400,000
University of FloridaFlorida1$299,801
Association of Schools and Programs of Public Health, Inc.District of Columbia1$55,999

Top states: Maryland ($6.5 million), District of Columbia ($1.3 million), Georgia ($700,000), Arizona ($400,000), Florida ($299,801).

Who usually wins

State and local governments received 65% of the money, nonprofits 26% and colleges and universities 9.6%.

Recipient typeAwardsAmountShare
State and local governments2$5.9 million65%
Nonprofits4$2.4 million26%
Colleges and universities4$874,7999.6%

By state

2 states have a page for this program: those that received at least $1 million or 10 awards. They are Maryland and District of Columbia.

Grants by recipient's state, fiscal 2021 to 2025
StateAwardsAmount
Maryland5$6.5 million
District of Columbia2$1.3 million
Georgia1$700,000
Arizona1$400,000
Florida1$299,801

Award amounts are federal obligations reported to USAspending.gov for fiscal 2021 to 2025; see how our data works.